Bipolar Disorder may be Linked to Parkinson's Disease: Study
News May 23, 2019 | Original story by the American Academy of Neurology
People who have bipolar disorder may be more likely to later develop Parkinson's disease than people who do not have bipolar disorder, according to a new study published in the May 22, 2019, online issue of Neurology®, the medical journal of the American Academy of Neurology.
"Previous studies have shown a relationship between depression and Parkinson's disease, but few studies have looked at whether there is a relationship between bipolar disorder and Parkinson's," said study author Mu-Hong Chen, MD, PhD, of Taipei Veterans General Hospital in Taiwan.
For the study, researchers examined a national Taiwanese health database for people were diagnosed with bipolar disorder between 2001 and 2009 and who had no history of Parkinson's disease, for a total of 56,340 people. They were matched with 225,360 people of the same age, sex and other factors who had never been diagnosed with bipolar disorder or Parkinson's disease as a control group. Then the two groups were followed until the end of 2011.
During the study, 372 of the people with bipolar disorder developed Parkinson's disease, or 0.7 percent, compared to 222 of those who did not have bipolar disorder, or 0.1 percent.
After adjusting for other factors that could affect the risk of developing Parkinson's disease, such as age, sex, use of antipsychotic medications, and medical issues such as traumatic brain injury and cerebrovascular diseases, people with bipolar disorder were nearly seven times as likely to develop Parkinson's disease as people who did not have bipolar disorder.
The people with bipolar disorder who developed Parkinson's disease did so at a younger age than the control group members who developed the disease -- 64 years old at diagnosis compared to 73 years old.
People who were hospitalized more often for bipolar disorder were more likely to develop Parkinson's disease than those who were hospitalized less than once per year. A total of 94 percent of those with bipolar disorder were hospitalized less than once per year; 3 percent were hospitalized one to two times per year; and 3 percent were hospitalized more than two times per year. Those who were hospitalized more than two times per year were six times more likely to develop Parkinson's disease than those who were hospitalized less than once per year. People who were hospitalized one to two times per year were four times more likely to develop Parkinson's disease than those who were hospitalized less than once per year.
"Further studies are needed to investigate whether these diseases share underlying processes or changes in the brain," Chen said. "These could include genetic alterations, inflammatory processes or problems with the transmission of messages between brain cells. If we could identify the underlying cause of this relationship, that could potentially help us develop treatments that could benefit both conditions."
A limitation of the study is it included only people who sought medical help for their bipolar disorder. Also, the database did not include information on family history of Parkinson's disease or environmental factors that could increase people's risk of developing the disease.
This article has been republished from materials provided by the American Academy of Neurology. Note: material may have been edited for length and content. For further information, please contact the cited source.
Mao-Hsuan Huang, Chih-Ming Cheng, Kai-Lin Huang, Ju-Wei Hsu, Ya-Mei Bai, Tung-Ping Su, Cheng-Ta Li, Shih-Jen Tsai, Wei-Chen Lin, Tzeng-Ji Chen, Mu-Hong Chen. Bipolar disorder and risk of Parkinson disease: A nationwide longitudinal study. Neurology, May 22, 2019; DOI: 10.1212/WNL.0000000000007649
Researchers who sequenced the fecal samples of over 3,000 healthy volunteers recently described the so-called B2 enterotype, which is deficient in some anti-inflammatory bacteria. Today, they published more data, showing the high prevalence of this particular enterotype across multiple disease diagnoses.READ MORE
New research may explain why an antioxidant that protects the brain is also associated with deterioration in areas susceptible to Alzheimer’s disease. The antioxidant, superoxide dismutase or SOD1, improves cognition, but an Iowa State University research team found SOD1’s protective benefits dramatically weaken when levels of tau proteins – a hallmark of Alzheimer’s disease – increase.